These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12899528)
1. Analysis of the vitamin D system in cutaneous malignancies. Kamradt J; Rafi L; Mitschele T; Meineke V; Gärtner BC; Wolfgang T; Holick MF; Reichrath J Recent Results Cancer Res; 2003; 164():259-69. PubMed ID: 12899528 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the vitamin D system in basal cell carcinomas (BCCs). Mitschele T; Diesel B; Friedrich M; Meineke V; Maas RM; Gärtner BC; Kamradt J; Meese E; Tilgen W; Reichrath J Lab Invest; 2004 Jun; 84(6):693-702. PubMed ID: 15077124 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Friedrich M; Rafi L; Mitschele T; Tilgen W; Schmidt W; Reichrath J Recent Results Cancer Res; 2003; 164():239-46. PubMed ID: 12899526 [TBL] [Abstract][Full Text] [Related]
4. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3). Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the vitamin D system in cutaneous squamous cell carcinomas. Reichrath J; Rafi L; Rech M; Mitschele T; Meineke V; Gärtner BC; Tilgen W; Holick MF J Cutan Pathol; 2004 Mar; 31(3):224-31. PubMed ID: 14984574 [TBL] [Abstract][Full Text] [Related]
6. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883 [TBL] [Abstract][Full Text] [Related]
7. 25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. Bareis P; Bises G; Bischof MG; Cross HS; Peterlik M Biochem Biophys Res Commun; 2001 Jul; 285(4):1012-7. PubMed ID: 11467853 [TBL] [Abstract][Full Text] [Related]
8. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium. Healy KD; Zella JB; Prahl JM; DeLuca HF Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504 [TBL] [Abstract][Full Text] [Related]
9. Autocrine metabolism of vitamin D in normal and malignant breast tissue. Townsend K; Banwell CM; Guy M; Colston KW; Mansi JL; Stewart PM; Campbell MJ; Hewison M Clin Cancer Res; 2005 May; 11(9):3579-86. PubMed ID: 15867263 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of vitamin D hydroxylase expression and activity in normal and malignant human prostate cells. Khorchide M; Lechner D; Cross HS J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):167-72. PubMed ID: 15860259 [TBL] [Abstract][Full Text] [Related]
11. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro. Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804 [TBL] [Abstract][Full Text] [Related]
12. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase, 1,25-dihydroxyvitamin D3 24-hydroxylase and vitamin D receptor gene expression by 8-bromo cyclic AMP in cultured human syncytiotrophoblast cells. Avila E; Díaz L; Halhali A; Larrea F J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):115-9. PubMed ID: 15225757 [TBL] [Abstract][Full Text] [Related]
13. Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin. Reichrath J; Welter C; Mitschele T; Classen U; Meineke V; Tilgen W; Seifert M J Pathol; 2003 Apr; 199(4):509-16. PubMed ID: 12635142 [TBL] [Abstract][Full Text] [Related]
14. Hydroxylases involved in vitamin D metabolism are differentially expressed in murine embryonic kidney: application of whole mount in situ hybridization. Yamagata M; Kimoto A; Michigami T; Nakayama M; Ozono K Endocrinology; 2001 Jul; 142(7):3223-30. PubMed ID: 11416045 [TBL] [Abstract][Full Text] [Related]
15. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas. Jones G; Ramshaw H; Zhang A; Cook R; Byford V; White J; Petkovich M Endocrinology; 1999 Jul; 140(7):3303-10. PubMed ID: 10385427 [TBL] [Abstract][Full Text] [Related]
16. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets. Malloy PJ; Zhu W; Zhao XY; Pehling GB; Feldman D Mol Genet Metab; 2001 Jun; 73(2):138-48. PubMed ID: 11386849 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas. Ng KY; Ma MT; Leung KK; Leung PS Stem Cell Rev Rep; 2011 Mar; 7(1):53-63. PubMed ID: 20354914 [TBL] [Abstract][Full Text] [Related]
18. Age-related alteration of vitamin D metabolism in response to low-phosphate diet in rats. Chau TS; Lai WP; Cheung PY; Favus MJ; Wong MS Br J Nutr; 2005 Mar; 93(3):299-307. PubMed ID: 15877868 [TBL] [Abstract][Full Text] [Related]
19. Rat kidney 25-hydroxyvitamin D3 1 alpha- and 24-hydroxylases: evidence for two distinct gene products. Arabian A; Grover J; Barré MG; Delvin EE J Steroid Biochem Mol Biol; 1993 Jun; 45(6):513-6. PubMed ID: 7686041 [TBL] [Abstract][Full Text] [Related]
20. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]